84182-46-7 Usage
General Description
3-(Benzyloxy)cyclobutane-1,1-dicarboxylic acid is a chemical compound that belongs to the class of carboxylic acids. It is a cyclobutane derivative with two carboxylic acid groups and a benzyl ether functional group. 3-(BENZYLOXY)CYCLOBUTANE-1,1-DICARBOXYLIC ACID has potential applications in organic synthesis and pharmaceutical research. The presence of the benzyl ether group makes it a versatile building block for the synthesis of various heterocyclic compounds and biologically active molecules. Additionally, its cyclobutane core structure gives it unique reactivity and potential for use in the development of novel drug candidates. Overall, 3-(benzyloxy)cyclobutane-1,1-dicarboxylic acid is a valuable chemical for the advancement of organic and medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 84182-46-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,4,1,8 and 2 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 84182-46:
(7*8)+(6*4)+(5*1)+(4*8)+(3*2)+(2*4)+(1*6)=137
137 % 10 = 7
So 84182-46-7 is a valid CAS Registry Number.
InChI:InChI=1/C13H14O5/c14-11(15)13(12(16)17)6-10(7-13)18-8-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H,14,15)(H,16,17)
84182-46-7Relevant articles and documents
BENZOFURAN DERIVATIVES FOR THE TREATMENT OF HEPATITIS C
-
, (2017/10/13)
The disclosure provides compounds of formula (I), including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
AZETIDINE AND CYCLOBUTANE DERIVATIVES AS JAK INHIBITORS
-
Page/Page column 41, (2009/09/28)
The present invention relates to azetidine and cyclobutane derivatives, as well as their compositions, methods of use, and processes for preparation, which are JAK inhibitors useful in the treatment of JAK-associated diseases including, for example, inflammatory and autoimmune disorders, as well as cancer.
NOVEL INTERMEDIATES AND THEIR USE
-
Page/Page column 16-17, (2010/11/27)
The invention is directed to novel acyloxy imidazole intermediates useful for making certain C- 14 oxycarbonyl carbamate pleuromutilin derivatives. The invention is further directed to a process for making such acyloxy imidazole intermediates and to a pro